Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management

BACKGROUND: The risk–benefit calculation for corticosteroid administration in the management of COVID-19 is complex and urgently requires data to inform the decision. The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation associated with poor prognosis in both COVID-19 and can...

Descripción completa

Detalles Bibliográficos
Autores principales: Marté, Jennifer L, Toney, Nicole J, Cordes, Lisa, Schlom, Jeffrey, Donahue, Renee N, Gulley, James L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681794/
https://www.ncbi.nlm.nih.gov/pubmed/33219091
http://dx.doi.org/10.1136/jitc-2020-001019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681794/
https://www.ncbi.nlm.nih.gov/pubmed/33219091
http://dx.doi.org/10.1136/jitc-2020-001019

Ejemplares similares